Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

por Saad, Carla GS, Ribeiro, Ana CM, Moraes, Julio CB, Takayama, Liliam, Goncalves, Celio R, Rodrigues, Marcelo B, de Oliveira, Ricardo M, Silva, Clovis A, Bonfa, Eloisa, Pereira, Rosa MR
Publicado 2012